{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:34:21Z","timestamp":1779114861935,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.orcp.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T17:10:21Z","timestamp":1570209021000},"page":"440-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The role of adipokines in the improvement of diabetic and cardiovascular risk factors within a 52-week weight-loss programme for obesity"],"prefix":"10.1016","volume":"13","author":[{"given":"Johannes","family":"Hausmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Waechtershaeuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imke","family":"Behnken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayseg\u00fcl","family":"Aksan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Blumenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan M.","family":"Loitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2019.09.006_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","article-title":"Obesity and cardiovascular disease: revisiting an old relationship","volume":"92","author":"Koliaki","year":"2019","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pcad.2018.06.004","article-title":"Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update","volume":"61","author":"Piche","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"13","key":"10.1016\/j.orcp.2019.09.006_bib0015","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","article-title":"Healthy weight and obesity prevention: JACC health promotion series","volume":"72","author":"Lavie","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"25 Suppl. 2","key":"10.1016\/j.orcp.2019.09.006_bib0020","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the obesity society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 3","key":"10.1016\/j.orcp.2019.09.006_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.orcp.2019.09.006_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ijo.2011.107","article-title":"Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life\u2014a prospective study","volume":"36","author":"Bischoff","year":"2012","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mcna.2017.08.006","article-title":"Guideline recommendations for obesity management","volume":"102","author":"Ryan","year":"2018","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-142-1-200501040-00012","article-title":"Systematic review: an evaluation of major commercial weight loss programs in the United States","volume":"142","author":"Tsai","year":"2005","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJR.0b013e3282f17bd4","article-title":"Calorie restriction and cardiometabolic health","volume":"15","author":"Fontana","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"6778","key":"10.1016\/j.orcp.2019.09.006_bib0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/35007508","article-title":"Obesity as a medical problem","volume":"404","author":"Kopelman","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.orcp.2019.09.006_bib0060","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atheroslcerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"10.1016\/j.orcp.2019.09.006_bib0065","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.orcp.2019.09.006_bib0070","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","article-title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages","volume":"103","author":"Ouchi","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.orcp.2019.09.006_bib0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MOL.0000000000000431","article-title":"Adiponectin, lipids and atherosclerosis","volume":"28","author":"Katsiki","year":"2017","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"10.1016\/j.orcp.2019.09.006_bib0080","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/oby.22354","article-title":"Oxidized HDL, adipokines, and endothelial dysfunction: a potential biomarker profile for cardiovascular risk in women with obesity","volume":"27","author":"Peterson","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.orcp.2019.09.006_bib0090","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/jcem.87.6.8550","article-title":"Decreased plasma adiponectin concentrations in women with dyslipidemia","volume":"87","author":"Matsubara","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.orcp.2019.09.006_bib0095","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/en.2016-1765","article-title":"Adiponectin and its receptors in diabetic kidney disease: molecular mechanisms and clinical potential","volume":"158","author":"Zha","year":"2017","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.orcp.2019.09.006_bib0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.orcp.2019.09.006_bib0105","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cmet.2016.02.009","article-title":"Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation","volume":"23","author":"Hayes","year":"2016","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.orcp.2019.09.006_bib0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/npp.2013.235","article-title":"Leptin signaling in the medial nucleus tractus solitarius reduces food seeking and willingness to work for food","volume":"39","author":"Kanoski","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.orcp.2019.09.006_bib0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.orcp.2019.09.006_bib0120","first-page":"229","article-title":"Leptin and obesity","volume":"100","author":"DA de","year":"2009","journal-title":"Minerva Med"},{"issue":"6","key":"10.1016\/j.orcp.2019.09.006_bib0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.orcp.2019.09.006_bib0130","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","article-title":"Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans","volume":"141","author":"Date","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.orcp.2019.09.006_bib0135","doi-asserted-by":"crossref","DOI":"10.1210\/en.2019-00074","article-title":"Ghrelin\u2019s relationship to blood glucose","author":"Mani","year":"2019","journal-title":"Endocrinology"},{"issue":"11\u201312","key":"10.1016\/j.orcp.2019.09.006_bib0140","first-page":"571","article-title":"Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance","volume":"49","author":"Pf\u00fctzner","year":"2003","journal-title":"Clin Lab"},{"key":"10.1016\/j.orcp.2019.09.006_bib0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fendo.2019.00140","article-title":"Molecular mechanisms underlying obesity-induced hypothalamic inflammation and insulin resistance: pivotal role of resistin\/TLR4 pathways","volume":"10","author":"Benomar","year":"2019","journal-title":"Front Endocrinol"},{"issue":"9492","key":"10.1016\/j.orcp.2019.09.006_bib0150","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.atherosclerosis.2012.05.005","article-title":"Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up","volume":"223","author":"M\u00e4ntyselk\u00e4","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.orcp.2019.09.006_bib0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J Cardiol"},{"issue":"5","key":"10.1016\/j.orcp.2019.09.006_bib0165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/dc18-0836","article-title":"Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial","volume":"42","author":"Salas-Salvad\u00f3","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/oby.2006.5","article-title":"Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots","volume":"14","author":"Rasmussen","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"14","key":"10.1016\/j.orcp.2019.09.006_bib0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0180","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1152\/ajpregu.00287.2005","article-title":"Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes","volume":"290","author":"Abbasi","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.orcp.2019.09.006_bib0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.metabol.2003.10.004","article-title":"Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women","volume":"53","author":"Abbasi","year":"2004","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.orcp.2019.09.006_bib0190","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.metabol.2007.03.010","article-title":"Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome","volume":"56","author":"Behre","year":"2007","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.orcp.2019.09.006_bib0195","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.ijo.0802977","article-title":"Changes in adipocyte hormones and lipid oxidation associated with weight loss and regain in severely obese adolescents","volume":"29","author":"Lazzer","year":"2005","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"10.1016\/j.orcp.2019.09.006_bib0200","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin","volume":"86","author":"Yang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.orcp.2019.09.006_bib0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nutres.2018.11.007","article-title":"Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults","volume":"62","author":"Mohorko","year":"2019","journal-title":"Nutr Res"},{"issue":"8","key":"10.1016\/j.orcp.2019.09.006_bib0210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.orcp.2019.09.006_bib0215","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2003.10.006","article-title":"Serum adiponectin in young adults\u2014interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study","volume":"14","author":"Steffes","year":"2004","journal-title":"Ann Epidemiol"},{"issue":"11","key":"10.1016\/j.orcp.2019.09.006_bib0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/CS20060296","article-title":"An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal women","volume":"112","author":"Polak","year":"2007","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41598-017-18709-9","article-title":"Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10.1016\/j.orcp.2019.09.006_bib0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2004.03.002","article-title":"Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects","volume":"219","author":"Lihn","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.orcp.2019.09.006_bib0235","article-title":"Adiponectin in cardiovascular inflammation and obesity","volume":"2011","author":"Aprahamian","year":"2011","journal-title":"Int J Inflam"},{"issue":"14","key":"10.1016\/j.orcp.2019.09.006_bib0240","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.orcp.2019.09.006_bib0245","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","article-title":"Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes","volume":"27","author":"Shetty","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.orcp.2019.09.006_bib0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/etm.2012.557","article-title":"Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus","volume":"4","author":"Uslu","year":"2012","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.orcp.2019.09.006_bib0255","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/ijo.2009.27","article-title":"Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects","volume":"33","author":"Belza","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10.1016\/j.orcp.2019.09.006_bib0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ijo.2008.278","article-title":"The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors","volume":"33","author":"Claessens","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10.1016\/j.orcp.2019.09.006_bib0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1753-4887.2011.00373.x","article-title":"Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans","volume":"69","author":"Klempel","year":"2011","journal-title":"Nutr Rev"},{"key":"10.1016\/j.orcp.2019.09.006_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.07.022","article-title":"Adipokines and severity and progression of coronary artery calcium: findings from the Rancho Bernardo Study","volume":"265","author":"Larsen","year":"2017","journal-title":"Atherosclerosis"},{"issue":"25","key":"10.1016\/j.orcp.2019.09.006_bib0275","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","article-title":"Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)","volume":"104","author":"Wallace","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.orcp.2019.09.006_bib0280","first-page":"1047","article-title":"Ghrelin and obesity: identifying gaps and dispelling myths. A reappraisal","volume":"31","author":"Makris","year":"2017","journal-title":"In Vivo"},{"issue":"21","key":"10.1016\/j.orcp.2019.09.006_bib0285","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery","volume":"346","author":"Cummings","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.orcp.2019.09.006_bib0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tsch\u00f6p","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.33549\/physiolres.931057","article-title":"Calcium intake and the outcome of short-term weight management","volume":"57","author":"Kabrnov\u00e1-Hlavat\u00e1","year":"2008","journal-title":"Physiol Res"},{"key":"10.1016\/j.orcp.2019.09.006_bib0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/DMSO.S13966","article-title":"Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants","volume":"3","author":"Vetter","year":"2010","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"14","key":"10.1016\/j.orcp.2019.09.006_bib0305","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2018.08.2141","article-title":"Promoting physical activity and exercise: JACC health promotion series","volume":"72","author":"Fletcher","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pcad.2018.07.004","article-title":"The joint association of fitness and fatness on cardiovascular disease mortality: a meta-analysis","volume":"61","author":"Barry","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"5\u20136","key":"10.1016\/j.orcp.2019.09.006_bib0315","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.pcad.2018.11.005","article-title":"An update on the role of cardiorespiratory fitness, structured exercise and lifestyle physical activity in preventing cardiovascular disease and health risk","volume":"61","author":"Ozemek","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pcad.2018.07.014","article-title":"The effects of exercise and physical activity on weight loss and maintenance","volume":"61","author":"Swift","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc06-1883","article-title":"Physical activity and metabolic risk in individuals with a family history of type 2 diabetes","volume":"30","author":"Ekelund","year":"2007","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.orcp.2019.09.006_bib0330","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.metabol.2007.03.009","article-title":"In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children","volume":"56","author":"Kelly","year":"2007","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.orcp.2019.09.006_bib0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051190","article-title":"Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives","volume":"20","author":"Yanai","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.orcp.2019.09.006_bib0340","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2007-978586","article-title":"An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls","volume":"32","author":"Okamoto","year":"2000","journal-title":"Horm Metab Res"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X19303308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X19303308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:25:58Z","timestamp":1761729958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X19303308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1871403X19303308"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2019.09.006","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of adipokines in the improvement of diabetic and cardiovascular risk factors within a 52-week weight-loss programme for obesity","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}